Consistent with our previous results in human BCP-ALL cells treated with drugs [27], the expression of Lgals3 was significantly induced in drug-treated BCP-ALL cells that had been isolated from mice treated for 8 days with 75 mg/kg nilotinib. The gene discussed is LGALS3; the disease is acute lymphoblastic leukemia.